{"id":58,"date":"2013-08-20T09:07:35","date_gmt":"2013-08-20T07:07:35","guid":{"rendered":"http:\/\/www.ideal.rwth-aachen.de\/?page_id=58"},"modified":"2013-09-13T09:54:39","modified_gmt":"2013-09-13T07:54:39","slug":"work-package-list","status":"publish","type":"page","link":"https:\/\/www.ideal.rwth-aachen.de\/?page_id=58","title":{"rendered":"Work Packages"},"content":{"rendered":"<\/div><\/div><\/div><\/div><\/div>
\n

Work Package List<\/h3>
<\/div><\/div><\/div>
\n
<\/span><\/span><\/div>
\n
WP no.<\/th>Work package title<\/th><\/tr>
1<\/th>Project Management and Coordination<\/a><\/td><\/tr>
2<\/th>Assessment of randomisation procedures and randomisation based tests in small population groups<\/a><\/td><\/tr>
3<\/th>Extrapolating dose-response information to small population groups<\/a><\/td><\/tr>
4<\/th>Adaptive design studies in small population groups<\/a><\/td><\/tr>
5<\/th>Optimal design in mixed models to analyse studies in small population groups<\/a><\/td><\/tr>
6<\/th>Design of pharmacogenetic small population group trials including cross-over trials, n-of-1 trials and enrichment trials<\/a><\/td><\/tr>
7<\/th>Simulation of clinical trials in small population groups<\/a><\/td><\/tr>
8<\/th>Genetic factors influencing the response to the therapy in small population group trials<\/a><\/td><\/tr>
9<\/th>Decision analysis in small population groups<\/a><\/td><\/tr>
10<\/th>Biomarker surrogate endpoints in small population groups<\/a><\/td><\/tr>
11<\/th>Dissemination<\/a><\/td><\/tr><\/tbody><\/table><\/div>